Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Source: Eur Respir J 2011; 37: 162-168 Year: 2011
Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006
Three dimensional evaluation of chemotherapy response in malign pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 754s Year: 2007
Evaluation of pleural disease with FDG-PET imaging Source: Annual Congress 2003 - Early lung cancer diagnosis Year: 2003
Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007
Clinical and radiological evaluation of pleural effusions at different volume ranges Source: Eur Respir J 2004; 24: Suppl. 48, 538s Year: 2004
Evaluate of radiological, bronchoscopical and histopathological features of patients with primary lung cancer Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Pleural pointillism and early contrast enhancement as imaging biomarkers of pleural malignancy Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020
Sonographic echogenic swirling pattern in patients with malignancies: a useful diagnostic predictor for malignant pleural effusions Source: Annual Congress 2008 - Imaging and measurement techniques in the evaluation of pulmonary embolism, COPD and pleural diseases Year: 2008
Relationship between baseline metabolic 18F-FDG parameters and survival in malignant pleural mesothelioma: A single centre experience Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Pericardial and pleural metastases: clinical and histological differences Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018
The surveillance of recurred/refractory lung malignancy using whole-body MRI: Correlation with the results assessed by PET-CT Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
PET predicts survival in malignant pleural mesothelioma Source: ISSN=ISSN 1810-6838, ISBN=, page=290 Year: 2007
Clinical usefulness of the novel drug sensitivity test for malignancy using pleural effusion Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity Year: 2006
Pathological diagnosis of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Correlation of HRCT findings with pleural fluid biochemical parameters and sputum bacteriology in tuberculous pelurisy: is it an extrapulmonary disease or not? Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Evaluation of chemotherapy response determined by volumetric method in malignant pleural mesothelioma and its effect on determination to survival Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006
Radiologic manifestations of primary pleural tumors Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010